Utilizing Biomaterials to Mimic Lung Diseases and Understand Cellular Repair Mechanisms
Gamber, Bennett
Gamber, Bennett
Citations
Altmetric:
License
0
License
DOI
Abstract
Idiopathic Pulmonary Fibrosis (IPF) affects roughly 250,000 globally with a 3-5 year survival rate after being diagnosed and no cure. There is a significant gap in the knowledge surrounding cellular and molecular lung repair which in turn has delayed advancement of therapeutic approaches for IPF. The implementation of novel human lung-derived biomaterials that mimic physiological pathways in lung diseases allows us to more effectively track cell repair behavior in experimental conditions. Pursuing this aspect of basic physiology can provide further insight into inflammatory and interstitial pulmonary diseases and future treatment therapeutic strategies.
Description
Undergraduate
Date
2024-01-01